Robert Bermel, MD is Staff Neurologist and Director of the Mellen Center for Multiple Sclerosis at Cleveland Clinic. He received a medical degree with thesis honors from the State University of New York at Buffalo, where his interest in MS began while training under Dr. Lawrence Jacobs, a pioneer in developing treatments for MS. Dr. Bermel completed neurology residency training and served as Chief Resident at Cleveland Clinic. He was funded as a National MS Society postdoctoral fellow in clinical neuroimmunology and advanced imaging at Cleveland Clinic.
Dr. Bermel cares for patients, conducts imaging research, and participates in clinical trials at the Cleveland Clinic Mellen Center. His current research interests include the dual use of standardized clinical assessments and imaging for both clinical care and large-scale observational research. Dr. Bermel serves on the steering committee and as site principal investigator for numerous ongoing clinical trials. Dr. Bermel has published in multiple peer-reviewed journals including Neurology, Annals of Neurology, JAMA Neurology, Lancet Neurology, Journal of Neuroimaging, and others. In 2012 Dr. Bermel organized the first multinational meeting on No Evidence of Disease Activity as a clinical treatment target in MS. He is a member of the annual meeting program committee for the American Society of Neuroimaging, chair of the fellowship grant review committee of the National MS Society, co-chair of the steering committee for the MS Partners Advancing Technology and Health Solutions (MS PATHS) collaborative research network, and serves as an ad hoc reviewer for multiple scholarly journals. He regularly presents his ongoing work at international conferences.
In May 2017 Dr. Bermel graduated from the Case Western Reserve University Weatherhead Executive MBA program. He regularly serves as a volunteer speaker to patient groups on behalf of the National MS Society, and is recognized by Best Doctors® as one of the top doctors in America for Neurology.